The Watch the Spot Trial
This study will compare two clinically accepted protocols for surveillance imaging in individuals who are found to have a small pulmonary nodule on chest computed tomography (CT) scans.
Checked against the public recordLast updated Aug 14, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Diagnostic
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Kaiser Permanente
- Interventions being studied
- Other: More Frequent Surveillance Strategy; Other: Less Frequent Surveillance Strategy
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: The target population includes adults with small lung nodules that may represent a new diagnosis of lung cancer, who typically would be managed by CT surveillance in usual clinical practice. Thus, we will enroll all patients: * aged ≥35 years * at least one nodule measuring ≤15 mm in average diameter on chest CT. Exclusion Criteria: * Pregnant Women * Age \<35 years * Known diagnosis of cancer (except non-melanoma skin cancer) within 5 years
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Kaiser Permanente Southern CaliforniaPasadena, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 14, 2025. Always confirm current availability with the study team.